Beta Bionics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Beta Bionics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BBNX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001674632
Board of directors
-
Adam Lezack · DirectorSince 2025
-
Christy Jones · DirectorSince 2025
-
Danny L. Dearen · DirectorSince 2025
-
Gerard J. Michel · DirectorSince 2025
-
Maria Palasis · DirectorSince 2025
-
Sean Carney · DirectorSince 2025
-
Sean Saint · Director · President & CEOSince 2025
Chief executives
Sean Saint
· President & CEO
Since January 2025
Board connections
2 of this board's directors also sit on 2 other boards.
- via Gerard J. Michel
- via Danny L. Dearen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,968,327
- 53 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Christy Jones Director | Open-market sale | −6,430 | $23.00 | $147,890 |
| Sep 16, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −30,779 | $20.13 | $619,640 |
| Sep 16, 2026 | Mensinger Mike Officer (Chief Product Officer) | Open-market sale | −2,650 | $22.00 | $58,300 |
| Sep 14, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −775 | $15.52 | $12,028 |
| Sep 9, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −36,870 | $18.46 | $680,723 |
| Sep 3, 2026 | Sean Saint Director, Officer (President & CEO) | Open-market sale | −5,641 | $20.08 | $113,259 |
| Sep 2, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −5,327 | $19.11 | $101,815 |
| Sep 2, 2026 | Mensinger Mike Officer (Chief Product Officer) | Open-market sale | −4,375 | $19.11 | $83,620 |
| Sep 2, 2026 | Feider Stephen Officer (Chief Financial Officer) | Open-market sale | −6,675 | $19.11 | $127,580 |
| Sep 2, 2026 | Sean Saint Director, Officer (President & CEO) | Open-market sale | −16,867 | $19.11 | $322,381 |
| Sep 2, 2026 | Russell Steven Jon Officer (Chief Medical Officer) | Open-market sale | −4,221 | $19.11 | $80,676 |
| Jun 29, 2026 | Feider Stephen Officer (Chief Financial Officer) | Option exercise | +4,896 | $5.10 | $24,970 |
| Jun 29, 2026 | Feider Stephen Officer (Chief Financial Officer) | Open-market sale | −4,896 | $17.03 | $83,379 |
| Jun 26, 2026 | Feider Stephen Officer (Chief Financial Officer) | Option exercise | +4,982 | $5.10 | $25,408 |
| Jun 26, 2026 | Feider Stephen Officer (Chief Financial Officer) | Open-market sale | −5,104 | $17.05 | $87,023 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.